SG11201400696XA - Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes - Google Patents

Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes

Info

Publication number
SG11201400696XA
SG11201400696XA SG11201400696XA SG11201400696XA SG11201400696XA SG 11201400696X A SG11201400696X A SG 11201400696XA SG 11201400696X A SG11201400696X A SG 11201400696XA SG 11201400696X A SG11201400696X A SG 11201400696XA SG 11201400696X A SG11201400696X A SG 11201400696XA
Authority
SG
Singapore
Prior art keywords
maltotriose
compositions
methods
same
damage caused
Prior art date
Application number
SG11201400696XA
Inventor
Zihua Ao
Juan M Gonzalez
Bradley J Taylor
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46846027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201400696X(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of SG11201400696XA publication Critical patent/SG11201400696XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
SG11201400696XA 2011-10-11 2012-09-06 Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes SG11201400696XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/270,607 US20130089638A1 (en) 2011-10-11 2011-10-11 Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
PCT/US2012/053855 WO2013055463A1 (en) 2011-10-11 2012-09-06 Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes

Publications (1)

Publication Number Publication Date
SG11201400696XA true SG11201400696XA (en) 2014-08-28

Family

ID=46846027

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201400696XA SG11201400696XA (en) 2011-10-11 2012-09-06 Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes

Country Status (15)

Country Link
US (1) US20130089638A1 (en)
EP (1) EP2765872A1 (en)
CN (2) CN103929979A (en)
AR (1) AR088035A1 (en)
BR (1) BR112014008498A2 (en)
CA (1) CA2852109A1 (en)
CO (1) CO6940418A2 (en)
EC (1) ECSP14000460A (en)
HK (2) HK1199797A1 (en)
MX (1) MX2014004060A (en)
PE (1) PE20142080A1 (en)
RU (1) RU2014110708A (en)
SG (1) SG11201400696XA (en)
TW (2) TW201325460A (en)
WO (1) WO2013055463A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017073752A1 (en) 2015-10-30 2017-05-04 株式会社ヤクルト本社 Method for producing dried microbial cells
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792183A (en) * 1971-08-10 1974-02-12 Nabisco Inc Cereal coating composition and process
JPS60258125A (en) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc Water-soluble dried material containing proteinic physiologically active substance
US4814267A (en) * 1984-09-18 1989-03-21 Michigan Biotechnology Institute Method for preparing high conversion syrups and other sweeteners
DE68912719T2 (en) * 1988-11-10 1994-07-21 Takeda Chemical Industries Ltd Acid urease preparations for alcoholic beverages.
US5145697A (en) * 1989-04-26 1992-09-08 Mpy Foods, Inc. Instant yogurt composition and process
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
ZA92452B (en) 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
DE69325595T2 (en) 1993-11-17 2000-03-16 Niro Holding As METHOD AND SPRAY DRYING DEVICE FOR PRODUCING AGGLOMERED POWDER
FI104465B (en) * 1995-06-14 2000-02-15 Valio Oy Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use
ES2243965T3 (en) * 1996-07-09 2005-12-01 Societe Des Produits Nestle S.A. DRYING PROCEDURE THROUGH SPRAYING.
US6223455B1 (en) 1999-05-03 2001-05-01 Acusphere, Inc. Spray drying apparatus and methods of use
US6463675B1 (en) 1999-09-29 2002-10-15 Niro A/S Process and a plant for spray drying
US6322994B1 (en) * 1999-11-04 2001-11-27 Genetix Limited Method of freeze-drying organisms
EP1260227A1 (en) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
FR2829147B1 (en) * 2001-08-30 2003-12-12 Agronomique Inst Nat Rech PROCESS FOR THE PREPARATION OF A LYOPHILIZED COMPOSITION CONTAINING LACTIC BACTERIA HAVING IMPROVED BACTERIAL VIABILITY AND ACTIVITY DURING AMBIENT TEMPERATURE STORAGE AND COMPOSITION OBTAINED
US6838097B1 (en) * 2001-12-14 2005-01-04 Stephen Tsengas Pet food product
ES2311729T5 (en) * 2002-06-28 2013-02-14 Biosearch S.A. Probiotic strains, a procedure for their selection, their compositions and their use
WO2006029467A1 (en) * 2004-09-16 2006-03-23 Btf Pty Ltd Rapid freeze drying process
EP1656930A1 (en) 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
JP5435870B2 (en) * 2004-12-21 2014-03-05 フイルメニツヒ ソシエテ アノニム Method for producing particles containing oil containing polyunsaturated fatty acid
EP1867699B1 (en) * 2005-03-31 2018-10-10 Mitsubishi Chemical Corporation Deterioration preventing agent
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US20090257995A1 (en) * 2005-11-18 2009-10-15 Idemitsu Kosan Co., Ltd. Harmful bacterium control agent containing bacillus thuringiensis
JP4889317B2 (en) * 2006-02-17 2012-03-07 オリエンタル酵母工業株式会社 Composition with high content of maltotriose and method for producing the same
EP1903291A1 (en) 2006-09-19 2008-03-26 Ima-Telstar S.L. Method and system for controlling a freeze drying process
JP2011507518A (en) * 2007-12-20 2011-03-10 アボット・ラボラトリーズ Stable nutrition powder
MX2010009351A (en) * 2008-02-25 2011-03-04 Novavax Inc Sugar glassified virus like particles (vlps).
CN101313715A (en) * 2008-07-09 2008-12-03 内蒙古蒙牛乳业(集团)股份有限公司 Liquid milk with additive vitamin suitable for baby of 12 to 36 months ages
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
LT2603100T (en) * 2010-08-13 2018-07-25 Advanced Bionutrition Corp. Dry storage stabilizing composition for biological materials

Also Published As

Publication number Publication date
PE20142080A1 (en) 2014-12-24
HK1250315A1 (en) 2018-12-14
EP2765872A1 (en) 2014-08-20
TW201325460A (en) 2013-07-01
WO2013055463A1 (en) 2013-04-18
CN103929979A (en) 2014-07-16
US20130089638A1 (en) 2013-04-11
CN107647394A (en) 2018-02-02
BR112014008498A2 (en) 2017-04-11
MX2014004060A (en) 2014-07-09
CA2852109A1 (en) 2013-04-18
TW201822640A (en) 2018-07-01
CO6940418A2 (en) 2014-05-09
HK1199797A1 (en) 2015-07-24
ECSP14000460A (en) 2015-06-30
AR088035A1 (en) 2014-05-07
RU2014110708A (en) 2015-11-20

Similar Documents

Publication Publication Date Title
HK1256896A1 (en) Methods and compositions to enable multiplex cold-pcr
IL231227A0 (en) Compounds and compositions as c-kit inhibitors
IL231226A0 (en) Compounds and compositions as c-kit inhibitors
PT2744765T (en) Ternesite as additive to portland cement
EP2694686A4 (en) COMPOSITION AND METHODS RELATED TO MODIFICATION OF 5-METHYLCYTOSINE (5mC)
SG11201400213QA (en) Poly alpha olefin compositions and process to produce poly alpha olefin compositions
SG10201504780PA (en) Semiconductor device and method of formingextended semiconductor device with fan-outinterconnect structure to reduce complexity ofsubstrate
EP2675471A4 (en) Hsa-related compositions and methods of use
HK1212251A1 (en) Topical compositions and methods of use
SG10201602147YA (en) Methods And Compositions For Predicting Response To Eribulin
EP2968244A4 (en) Compositions and methods for utilization of algal compounds
HK1198387A1 (en) Thiophen-2-carboxylic acid derivatives useful as inhibitors of flaviviridae viruses -2-
EP2892315A4 (en) Methods and compositions to reduce soil water repellency
GB2502915B (en) Radiation-induced thickening for set-on-command sealant compositions and methods of use
EP2691105A4 (en) Methods and compositions related to inhibition of viral entry
EP2683411A4 (en) Methods of using microrna-26a to promote angiogenesis
ME02167B (en) Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine
HK1250315A1 (en) Compositions comprising maltotriose and use of same to inhibit damage caused by dehydration processes
IL236692A0 (en) Method for inducing cells to less mature state
EP2751071A4 (en) Fatty acid amides, compositions and methods of use
GB201113596D0 (en) Compounds, compositions and methods to promote oligodendrogenesis and remyelination
TWM386035U (en) Structure of anvil block to prevent slipping
HRP20150141T1 (en) Use of nifuratel to treat infections caused by clostridium species
IL239623A0 (en) Methods and compositions for admisitration of oxybutynin
HK1198657A1 (en) Addition of iron to improve cell culture